GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $84,574,000 | +251.0% | 389,919 | +86.7% | 0.02% | +233.3% |
| Q4 2020 | $24,098,000 | -13.5% | 208,806 | -27.0% | 0.01% | -25.0% |
| Q3 2020 | $27,862,000 | -77.6% | 286,197 | -71.8% | 0.01% | -82.2% |
| Q2 2020 | $124,592,000 | +22.1% | 1,015,250 | -12.8% | 0.04% | -2.2% |
| Q1 2020 | $102,001,000 | +93.6% | 1,164,786 | +131.2% | 0.05% | +100.0% |
| Q4 2019 | $52,673,000 | -65.8% | 503,762 | -62.4% | 0.02% | -68.1% |
| Q3 2019 | $154,026,000 | +31.7% | 1,339,006 | +97.4% | 0.07% | +35.8% |
| Q2 2019 | $116,938,000 | -17.4% | 678,334 | -19.3% | 0.05% | -24.3% |
| Q1 2019 | $141,625,000 | +91.6% | 840,153 | +10.7% | 0.07% | +75.0% |
| Q4 2018 | $73,915,000 | -65.7% | 758,957 | -39.2% | 0.04% | -58.3% |
| Q3 2018 | $215,544,000 | +136.9% | 1,247,801 | +91.3% | 0.10% | +108.7% |
| Q2 2018 | $91,003,000 | -18.1% | 652,161 | -33.8% | 0.05% | -23.3% |
| Q1 2018 | $111,049,000 | +3.9% | 985,610 | +21.8% | 0.06% | -6.2% |
| Q4 2017 | $106,837,000 | +277.7% | 809,310 | +190.4% | 0.06% | +190.9% |
| Q3 2017 | $28,285,000 | +146.2% | 278,699 | +143.2% | 0.02% | +120.0% |
| Q2 2017 | $11,489,000 | -25.0% | 114,595 | -9.6% | 0.01% | -28.6% |
| Q1 2017 | $15,327,000 | -32.7% | 126,731 | -37.8% | 0.01% | -36.4% |
| Q4 2016 | $22,773,000 | +3.3% | 203,774 | +22.7% | 0.02% | 0.0% |
| Q3 2016 | $22,042,000 | +266.2% | 166,064 | +152.7% | 0.02% | +214.3% |
| Q2 2016 | $6,019,000 | +230.7% | 65,726 | +160.6% | 0.01% | +250.0% |
| Q1 2016 | $1,820,000 | -48.9% | 25,222 | -50.8% | 0.00% | -50.0% |
| Q4 2015 | $3,560,000 | +37.3% | 51,263 | +80.7% | 0.00% | +100.0% |
| Q3 2015 | $2,592,000 | +197.2% | 28,369 | +299.6% | 0.00% | +100.0% |
| Q2 2015 | $872,000 | +80.2% | 7,099 | +33.7% | 0.00% | – |
| Q1 2015 | $484,000 | -43.5% | 5,308 | -58.0% | 0.00% | -100.0% |
| Q4 2014 | $856,000 | -59.3% | 12,653 | -51.4% | 0.00% | -50.0% |
| Q3 2014 | $2,103,000 | -77.1% | 26,014 | -69.6% | 0.00% | -81.8% |
| Q2 2014 | $9,194,000 | +191.2% | 85,690 | +61.1% | 0.01% | +175.0% |
| Q1 2014 | $3,157,000 | – | 53,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |